This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jackson, J. G.
Right arrow Articles by Pereira-Smith, O. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, J. G.
Right arrow Articles by Pereira-Smith, O. M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 2006, p. 2501-2510, Vol. 26, No. 7
0270-7306/06/$08.00+0     doi:10.1128/MCB.26.7.2501-2510.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Primary and Compensatory Roles for RB Family Members at Cell Cycle Gene Promoters That Are Deacetylated and Downregulated in Doxorubicin-Induced Senescence of Breast Cancer Cells

James G. Jackson* and Olivia M. Pereira-Smith

University of Texas Health Science Center at San Antonio, Department of Cellular and Structural Biology, Sam and Ann Barshop Institute for Longevity and Aging Studies, STCBM Building, 15355 Lambda Drive, San Antonio, Texas 78245-3207

Received 19 December 2005/ Returned for modification 12 January 2006/ Accepted 18 January 2006

When treated with DNA-damaging chemotherapy agents, many cancer cells, in vivo and in vitro, undergo a terminal growth arrest and acquire a senescence-like phenotype. We investigated the molecular basis for this in breast cancer cells following a 2-hour treatment with 1 µM doxorubicin. Treated cells arrested in G1 and G2 phases of the cell cycle, with concomitant reductions in S-phase and G2-M regulatory genes. p53 and p21 protein levels increased within hours after treatment and were maintained for 5 to 6 days but were reduced 8 days posttreatment, though the cells remained growth arrested. Levels of p130 rose after drug treatment, and it was the primary RB family member recruited to the S-phase promoters cyclin A and PCNA and G2-M promoters cyclin B and cdc2, remaining present for the entire 8-day time period. In contrast, p107 protein and promoter occupancy levels declined sharply after drug treatment. RB was recruited to only the PCNA promoter. In MCF-7 cells with p130 knockdown, p107 compensated for p130 loss at all cell cycle gene promoters examined, allowing cells to retain the growth arrest phenotype. Cells with p130 and p107 knockdown similarly arrested, while cells with knockdown of all three family members failed to downregulate cyclin A and cyclin B. These results demonstrate a mechanistic role for p130 and compensatory roles for p107 and RB in the long-term senescence-like growth arrest response of breast cancer cells to DNA damage.

* Corresponding author. Mailing address: Department of Cellular and Structural Biology, Sam and Ann Barshop Institute for Longevity and Aging Studies, STCBM Building, 15355 Lambda Drive, San Antonio, TX 78245-3207. Phone: (210) 562-5075. Fax: (210) 562-5093. E-mail: jacksonjg{at}uthscsa.edu.

Molecular and Cellular Biology, April 2006, p. 2501-2510, Vol. 26, No. 7
0022-538X/06/$08.00+0     doi:10.1128/MCB.26.7.2501-2510.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Lee, S. L. O., Hong, S.-W., Shin, J.-S., Kim, J. S., Ko, S.-G., Hong, N.-J., Kim, D. J., Lee, W.-J., Jin, D.-H., Lee, M.-S. (2009). p34SEI-1 Inhibits Doxorubicin-Induced Senescence through a Pathway Mediated by Protein Kinase C-{delta} and c-Jun-NH2-Kinase 1 Activation in Human Breast Cancer MCF7 Cells. Mol Cancer Res 7: 1845-1853 [Abstract] [Full Text]  
  • Ottewell, P. D., Woodward, J. K., Lefley, D. V., Evans, C. A., Coleman, R. E., Holen, I. (2009). Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone. Molecular Cancer Therapeutics 8: 2821-2832 [Abstract] [Full Text]  
  • Huang, B., Deo, D., Xia, M., Vassilev, L. T. (2009). Pharmacologic p53 Activation Blocks Cell Cycle Progression but Fails to Induce Senescence in Epithelial Cancer Cells. Mol Cancer Res 7: 1497-1509 [Abstract] [Full Text]  
  • Su, D., Zhu, S., Han, X., Feng, Y., Huang, H., Ren, G., Pan, L., Zhang, Y., Lu, J., Huang, B. (2009). BMP4-Smad Signaling Pathway Mediates Adriamycin-induced Premature Senescence in Lung Cancer Cells. J. Biol. Chem. 284: 12153-12164 [Abstract] [Full Text]  
  • Mannefeld, M., Klassen, E., Gaubatz, S. (2009). B-MYB Is Required for Recovery from the DNA Damage-Induced G2 Checkpoint in p53 Mutant Cells. Cancer Res. 69: 4073-4080 [Abstract] [Full Text]  
  • Schmitt, C. A (2008). In vivo Complexities of Cellular Senescence in Tumor Development and Therapy. aacredbook 2008: 499-504 [Abstract] [Full Text]  
  • Qian, Y., Zhang, J., Yan, B., Chen, X. (2008). DEC1, a Basic Helix-Loop-Helix Transcription Factor and a Novel Target Gene of the p53 Family, Mediates p53-dependent Premature Senescence. J. Biol. Chem. 283: 2896-2905 [Abstract] [Full Text]  
  • Rada-Iglesias, A., Enroth, S., Ameur, A., Koch, C. M., Clelland, G. K., Respuela-Alonso, P., Wilcox, S., Dovey, O. M., Ellis, P. D., Langford, C. F., Dunham, I., Komorowski, J., Wadelius, C. (2007). Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes. Genome Res 17: 708-719 [Abstract] [Full Text]  
  • Dalmizrak, O., Wu, A., Chen, J., Sun, H., Utama, F. E., Zambelli, D., Tran, T. H., Rui, H., Baserga, R. (2007). Insulin Receptor Substrate-1 Regulates the Transformed Phenotype of BT-20 Human Mammary Cancer Cells. Cancer Res. 67: 2124-2130 [Abstract] [Full Text]  
  • Johung, K., Goodwin, E. C., DiMaio, D. (2007). Human Papillomavirus E7 Repression in Cervical Carcinoma Cells Initiates a Transcriptional Cascade Driven by the Retinoblastoma Family, Resulting in Senescence. J. Virol. 81: 2102-2116 [Abstract] [Full Text]  
  • Jackson, J. G., Pereira-Smith, O. M. (2006). p53 Is Preferentially Recruited to the Promoters of Growth Arrest Genes p21 and GADD45 during Replicative Senescence of Normal Human Fibroblasts.. Cancer Res. 66: 8356-8360 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»